TARC (thymus- and activation-regulated chemokine, CCL17) and MDC (macrophage-derived chemokine, CCL22) are two Th2 cell-producing chemokines that are involved in the pathogenesis of AD and their expression levels are known to be significantly higher in AD patients when compared to normal subjects [7]. Here, CCL17 is linked to Alzheimer disease.